Study: Real-Time Analytics, Continuous Monitoring Mitigates Threat of Respiratory Depression

Peer-reviewed results of patented surveillance application reveals promise of real-time patient safety initiatives in hospitals and health systems

Milford, CT—May 24, 2017—Bernoulli, the leader in real-time solutions for patient safety, announced the publication of a peer-reviewed study demonstrating the use of patented real-time analytics, medical device connectivity and combinatorial alarms to provide remote centralized continuous monitoring of post-surgical patients at risk for opioid-induced respiratory depression (OIRD).

Continuous Surveillance of Sleep Apnea Patients in a Medical-Surgical Unit1 in the May/June 2017 issue of the Journal of Biomedical Instrumentation & Technology consists of two separate studies on the use of continuous capnography monitoring at a medical-surgical unit at Virtua Health System in New Jersey.

The study’s results suggest that combinatorial alarm signals based on multi-parameter assessment reduced overall load better than individual-parameter sustained alarm signals and appeared to be more effective at identifying at-risk patients.

Using only sustained alarms as the filter for notifications reduced alerts from 22,812 to 13,000. However, passing multiple series of data through a multi-variable rules engine that monitored the values of pulse (HR), oxygen saturation (SpO2), respiratory rate (RR), and end-tidal carbon dioxide (ETCO2) in order to determine which alarms to send to the nurse-call phone system further reduced alerts to just 209—a 99% reduction.

“More importantly, clinical staff was alerted for every patient that experienced an actual respiratory depression episode,” said the study’s co-author, John Zaleski, PhD, CAP, CPHIMS, Chief Analytics Officer of Bernoulli. “The successful implementation of real-time patient safety initiatives have long been a goal of health system CIOs, but recognizing and responding to signs of patient deterioration requires medical devices connectivity as well as clinician’s access to real-time data.”

A Growing Patient Safety Threat
The use of opioids, such as hydromorphone and morphine sulfate, are known to increase risk of respiratory depression in patients who have been diagnosed with or are at risk for obstructive sleep apnea (OSA).

More than half of medication-related deaths and 20,000 incidences of respiratory depression-related interventions annually are attributed to the delivery of opioids in a care setting, at a cost of approximately $2 billion per year to the U.S. healthcare system.

“Data from multiple sources may be required to achieve improvements in patient safety, including the EHR and real-time data from medical devices,” said Zaleski. “Moment-to-moment changes in patient vitals are not usually available in the long-term clinical record, so a hybrid approach involving both real-time and aperiodic and discrete data is required to improve the overall surveillance of these patients.”

Respiratory Depression Safety Surveillance
The solution leveraged in the study, Bernoulli’s Respiratory Depression Safety Surveillance (RDSS), includes patented analytics with multi-variable thresholds—adjustable by the care facility—to identify clinically actionable events while significantly reducing the overall number of alarms communicated to remote and mobile clinicians, mitigating the risk of alarm fatigue.

RDSS is flexible, adaptable and scalable from individual departments to enterprise-wide deployments. Its vendor-neutral architecture leverages the hospital’s existing investments in IT, network, wireless and mobile infrastructure, while its FDA class II clearance includes indications for use to provide remote monitoring and alarm surveillance.

Implications for Real-Time Healthcare
“Combining analysis with real-time data at the point of collection creates a powerful tool for prediction and clinical decision support,” said Zaleski. “The ability to track patients throughout the hospital, continuously add new devices, and distribute real-time patient monitoring to centralized dashboards and mobile devices should be a major consideration for CIOs tasked with achieving real-time healthcare capabilities.”

Beyond high-acuity areas, healthcare systems are creating a foundation for other real-time healthcare innovations, including clinical surveillance modules, medical device integration in an EHR and virtual ICUs.

“This study demonstrates the promise of using real-time data for myriad patient safety initiatives,” said Janet Dillione, CEO of Bernoulli. “In addition, Bernoulli’s RDSS solution sets the stage for a wide range of applications, including medical device integration, precision alarm notifications, and clinical surveillance modules in various care settings.”

Reference
1. Supe D, Baron L, Decker T, Parker K, Venella J, Williams S, Beaton K, Zaleski J. A pilot study in middleware-filtered capnography alarms of continuously monitored obstructive sleep apnea patient in a medical-surgical unit. BI&T. May/June 2017.

Bernoulli One™ is the market’s only real-time, connected healthcare platform that combines comprehensive and vendor-neutral medical device integration with powerful middleware, clinical surveillance, telemedicine/virtual ICU, advanced alarm management, real-time analytics and robust distribution capabilities into ONE solution that empowers clinicians with tools to drive better patient safety, clinical outcomes, patient experience, and provider workflow.

About Bernoulli

Bernoulli is the leader in real-time solutions for patient safety, with more than 1,200 installed, operational systems. Bernoulli One™ is the market’s only real-time, connected healthcare platform that combines comprehensive and vendor-neutral medical device integration with powerful middleware, clinical surveillance, telemedicine/virtual ICU, advanced alarm management, real-time analytics and robust distribution capabilities into ONE solution that empowers clinicians with tools to drive better patient safety, clinical outcomes, patient experience, and provider workflow. For more information about Bernoulli One™, visit www.bernoullihealth.com. Follow us on LinkedIn and Twitter . Visit our Resource Center to download case studies, white papers and articles.

Neil A Halpern MD & Amar Setty MD

Physician Advisors to Consult on Real-Time Healthcare & Patient Safety Issues

Expertise will Provide Valuable Insights on Supporting Clinical Workflow and Driving Improved Quality of Care

Milford, CT—March 27, 2017—Bernoulli, the leader in real-time solutions for patient safety, announced that two prominent physicians will join the company as consultants to explore issues related to real-time healthcare delivery and increased patient safety.

Neil A. Halpern, MD, MCCM, FCCP, FACP, is Director of the Critical Care Center, Chief of the Critical Care Medicine Service and Medical Director of Respiratory Therapy at Memorial Sloan Kettering (MSK) Cancer Center in New York. Dr. Halpern oversees a team of highly experienced doctors, nurse practitioners, physician assistants, respiratory therapists, research and bedside nurses, and critical care programmers who help provide care for patients in MSK’s adult medical-surgical intensive care unit (ICU).

Since 2000, he has co-chaired the hospital’s Clinical Device and Product Evaluation Committee, and since 2014, the Alarm Committee at MSK. Between 2005 and 2007, he chaired the multidisciplinary ICU Design Committee that developed the plan and monitored the construction of MSK’s 20-bed medical-surgical adult ICU, which opened in April 2007.

“There is a clear need in healthcare for greater connectivity, interoperability and comprehensive real-time data to support improved patient safety, enhanced care team collaboration and proactive clinical intervention,” said Dr. Halpern. “I look forward to advising Bernoulli on the applications and services that will have the greatest impact.”

Amar Setty, MD, is the CEO of AnesthesiaStat, a Baltimore-based anesthesia consulting and management company operated by practicing, Board Certified anesthesiologists. In addition to an active private practice, Dr. Setty serves as the immediate-Past President of the Maryland Society of Anesthesiologists, where he continues to be an advocate.

He is working to develop data-centric applications for patient-advocated value-based care, ultrasound/video-based artificial intelligence for medical procedures, as well as an app for patient empowerment in chronic pain. He has a unique interest in the use of technology to improve the perioperative experience and is working to build a new system of surgical risk prediction and management. He hopes to improve the quality and care of patients before and after discharge.

“The complexity and exponential growth of patient-generated data in modern care settings can be overwhelming, and even act as a barrier to real-time patient care and interventions if not properly managed,” said Dr. Setty. “I am excited to sharing my perspectives and experiences as a physician with Bernoulli to better facilitate the use of comprehensive real-time patient data to improve patient safety, quality and cost of care.”

“Many of the challenges facing healthcare providers – including mitigating patient safety threats, embarking on value-based care initiatives, and streamlining clinical workflows – require comprehensive real-time data, surveillance and analytics,” said Janet Dillione, CEO of Bernoulli. “Dr. Setty and Dr. Halpern’s clinical expertise will help uncover valuable insights, enabling us to better align our solutions with the needs of hospitals and health systems.”

 

About Bernoulli

Bernoulli is the leader in real-time solutions for patient safety, with more than 1,200 installed, operational systems. Bernoulli One™ is the market’s only real-time, connected healthcare platform that combines comprehensive and vendor-neutral medical device integration with powerful middleware, clinical surveillance, telemedicine/virtual ICU, advanced alarm management, predictive analytics and robust distribution capabilities into ONE solution that empowers clinicians with tools to drive better patient safety, clinical outcomes, patient experience, and provider workflow. For more information about Bernoulli, visit www.bernoullihealth.com. Follow us on Twitter and LinkedIn. Visit our Resource Center to download case studies, white papers and articles.

Bernoulli Demonstrates Real-Time Patient Data and Waveform Delivery with Voalte and Connexall at HIMSS17

Bernoulli will join Voalte and Connexall for a unique integration demonstration delivering alerts paired with real-time patient data and waveforms to smartphones. The demonstration will be held at Booth 673 at the 2017 Annual HIMSS Conference & Exhibition (HIMSS17) in Orlando next week. Click here for more details.

Witness real-time data delivery with Bernoulli at HIMSS17

Immediate delivery of real-time data anytime and from anywhere remains a huge challenge for doctors, nurses and other care providers.

In the HIMSS17 Exhibit Hall, Bernoulli will co-host live presentations featuring Bernoulli One™, an award-winning platform that instantly provides caregivers a real-time, holistic and medically contextual portrait of a patient’s condition—critical ingredients for proactive clinical intervention, enhanced care team collaboration, and significantly improved patient safety.

As you tour the Exhibit Hall, be sure to add these live demonstrations to your list of must-see events:

  • Booth 673. Bernoulli middleware routes real-time patient data, including waveforms and alarms, through Connexall’s enterprise platform to the Voalte app to support accurate patient assessments and clinical decision-making.
  • Booth 3315. Bernoulli demonstrates proactive patient interventions using real-time clinical surveillance and alarm management data delivered through PerfectServe’s secure mobile communication platform.
  • Booth 815. Bernoulli partners with PatientSafe Solutions to demonstrate how access to real-time patient alarms, data and waveforms delivered on a secure communication platform seamlessly extends hospital communications and patient infrastructure throughout an organization.

Visit the HIMSS Interoperability Showcase

Bernoulli leverages Bernoulli One™ in Surgery & Recovery and Childhood Asthma use cases at Booth #9000, as well as integration of patient data and waveforms into Epic.

 

About Bernoulli

Bernoulli is the leader in real-time solutions for patient safety, with more than 1,200 installed, operational systems. Bernoulli One™ is the market’s only real-time, connected healthcare platform that combines comprehensive and vendor-neutral medical device integration with powerful middleware, clinical surveillance, telemedicine/virtual ICU, advanced alarm management, predictive analytics and robust distribution capabilities into ONE solution that empowers clinicians with tools to drive better patient safety, clinical outcomes, patient experience, and provider workflow. For more information about Bernoulli, visit www.bernoullihealth.com. Follow us on Twitter and LinkedIn. Visit our Resource Center to download case studies, white papers and articles.

 

Media contact:

Matt Schlossberg
Amendola Communications for Bernoulli

 

Bernoulli Exhibits at the HIMSS Interoperability Showcase™

Look for Bernoulli at the Surgery & Recovery and Childhood Asthma Use Cases; also showing integration of patient data and waveforms into Epic

Milford, CT—February 8, 2017—Bernoulli, the leader in real-time solutions for patient safety, will brings its award-winning Bernoulli One™ connectivity platform to the HIMSS Interoperability Showcase (booth #9000) at the 2017 Annual HIMSS Conference & Exhibition in Orlando, from Feb. 19–23.

As an Interoperability Showcase™ participant, Bernoulli will be demonstrating Use Cases in Surgery & Recovery and Childhood Asthma with its Bernoulli One™ platform, the market’s only real-time, connected healthcare platform that combines comprehensive and vendor-neutral medical device integration with powerful middleware, clinical surveillance, telemedicine/virtual ICU, advanced alarm management, predictive analytics and robust distribution capabilities into a single solution that empowers clinicians with tools to drive better patient safety, clinical outcomes, patient experience, and provider workflow. Bernoulli also will be showing integration of patient data and waveforms into Epic.

“Bernoulli has long been committed to advancing industry-wide interoperability to support better patient safety, quality and reduced cost of care,” said Janet Dillione, CEO of Bernoulli. “The HIMSS Interoperability Showcase is the ideal platform to demonstrate our solution’s capabilities, as well as the decades of experience we can provide to stakeholders seeking to achieve true, patient-centered interoperability.”

Participants demonstrate health IT solutions to decision makers at the HIMSS Interoperability Showcase—a 34,000-square-foot exhibition that displays, in real time, the exchange and use of data through interoperability profiles and standards with live products currently in the marketplace. The showcase has expanded to include all interoperability stakeholders and to demonstrate the entire health ecosystem, with no technical barriers to health IT solutions providers to participate.

Due to the shift from fee-for-service to value-based models that stimulate the demand for interoperability, the HIMSS Interoperability Showcase™ has been redesigned, to move from beyond focusing on the EHR as the sole data source for electronic health information, to a wide range of health information technologies used by individuals, providers and researchers. While previous showcases have focused on transactional interoperability, the redesigned showcase reflects interoperability’s current state by placing individuals at the center of their care. The showcase will emphasize the importance of individuals being responsible for and connected directly to their health information, as well as the driving force that makes this connection possible: IT.

The updated showcase features a welcome area with interactive gateway stations; a more targeted approach to tours, utilizes personas; and enhanced education and networking events.

“The HIMSS Interoperability Showcase is a unique experience, where healthcare stakeholders come together to demonstrate the benefits of using standards-based interoperable health IT solutions for effective and secure health data information exchange,” said Joyce Sensmeier, vice president, informatics, HIMSS North America. “The redesigned Interoperability Showcase provides attendees with the opportunity to explore an ecosystem where standards-based health IT enables individuals to securely access, contribute to and analyze their own health data – with a wide variety of scenarios and expressions of interoperability in different of care settings.”

HIMSS17 Interoperability Showcase hours are:

  • Monday, Feb. 20, 10 a.m. – 6 p.m.
  • Tuesday, Feb. 21, 9:30 a.m. – 6 p.m.
  • Wednesday, Feb. 22, 9:30 a.m. – 4 p.m.

Links to the Interoperability Showcase tours and demonstrations can be found here and here.

 

About Bernoulli

Bernoulli is the leader in real-time solutions for patient safety, with more than 1,200 installed, operational systems. Bernoulli One™ is the market’s only real-time, connected healthcare platform that combines comprehensive and vendor-neutral medical device integration with powerful middleware, clinical surveillance, telemedicine/virtual ICU, advanced alarm management, predictive analytics and robust distribution capabilities into ONE solution that empowers clinicians with tools to drive better patient safety, clinical outcomes, patient experience, and provider workflow. For more information about Bernoulli follow us on Twitter and LinkedIn. Visit our Resource Center to download case studies, white papers and articles.

 

 

Media contacts:

Matt Schlossberg
Amendola Communications